8/14/2019 Hytrin Card#9

1/1

Terazosin (hytrin)

Classification: Antihypertensives, peripherally acting anti-adrenergics

Indication (Use): Mild to moderate hypertension (alone or with other agents) Urinary outflow

obstruction, in pts /c prostatic hyperplasia

Normal dosage: Adult ~ PO Hypertension~1mg initially, then slowly increased up to 5mg/day

(usual range 1-5mg/day); may be given as single dose or in 2 divided doses (not to exceed

20mg/day) Benign Prostatic Hyperplasia~1 mg at bedtime; gradually may be increased up to 5

mg/day

Side Effects: CNS: H/A, dizziness, weakness, drowsiness, nervousness EENT: nasal

congestion,blurred vision, conjunctivitis, sinusitis CV: first-dose orthostatic hypertension,

arrhythmias, chest pain, palpitations, peripheral edema, tachycardia GI: abd pain, diarrhea,nausea, dry mouth, vomiting GU: ED, urinary frequency RESP: dyspnea Derm:pruritus

Metab: weight gain Ms: arthralgia, back pain, ext. pain Misc: fever

Nursing implications: Monitor B/P lying and standing, P. frequently during initial dose, Assess

for first-dose orthostatic reaction and Chk frequency of Rx refill to ensure compliance, Monitor

V/S q 5-15 min during and /p drug admin, Monitor I/O and daily weight esp at the beginning of

therapy.

Patient teaching: Explain the purpose of the medication; thoroughly explain possible side

effects and what adverse reaction to looks for, contact Primary care provider (PCP) if any

questions or concerns. No double doses, weight checks biweekly and assess feet and hands for

fluid retention, may cause dizziness or drowsiness, call PCP prior to taking any cold or cough

medicine.